Fractional flow reserve (FFR)

Incorporating Coronary CTA and HeartFlow Into the Clinical Workflow

01/07/2019

Daniel I. Simon, MD, FACC, FAHA

We embraced HeartFlow technology for two reasons: one is its accuracy as a go-to diagnostic test, but the other is the power it holds in helping to plan interventions for patients before getting to the cath lab.

We embraced HeartFlow technology...

01/07/2019

Cath Lab Digest

Clinical Editor's Corner

Return of IC Adenosine for FFR: History, Dose and Technique

12/04/2015

Morton Kern, MD
Clinical Editor; Chief of Medicine,
Long Beach Veterans
Administration Health Care
System, Long Beach, California;
Associate Chief Cardiology,
Professor of Medicine,
University of California Irvine,
Orange, California
mortonkern2007@gmail.com

Morton Kern, MD Clinical Editor; Chie...

Several thought leaders in coronary physiology recommend returning to intracoronary (IC) adenosine. I thought it might be worthwhile to discuss how IC adenosine came to be used, its best dosing, and a couple tips on technique for...

Several thought leaders in...

12/04/2015

Cath Lab Digest

Technology Pulse

The Use of iFR Measurements to Simplify Decision Making for PCI

04/30/2015

Vincent J. Pompili, MD, FACC, FSCAI, Professor of Internal Medicine, Director, Interventional Cardiovascular Medicine and Cardiac Catherization Laboratories, The Richard M. Ross Heart Hospital, The Ohio State University Wexner Medical Center, Columbus, Ohio

Vincent J. Pompili, MD, FACC, FSCAI, ...

iFR assesses whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia without the requirement of running adenosine.

iFR assesses whether a stenosis...

04/30/2015

Cath Lab Digest

Limitations of FFR (or any Physiologic Measurement) During STEMI: Implications for FFR-Guided Revascularization in the ACS Patient

04/03/2015

Morton Kern, MD

A 48-year-old man comes to the emergency room with 2 hours of chest pain and electrocardiogram (ECG) showing inferior ST elevation (Figure 1)..

A 48-year-old man comes to the...

04/03/2015

Cath Lab Digest

Clinical and Economic Advantages of the iFR Modality for Physiologic Assessment

12/05/2014

Bruce A. Samuels, MD, Division of Cardiology, Cedars-Sinai Medical Center; Assistant Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, California

Bruce A. Samuels, MD, Division of Car...

Approved by the FDA in March 2014, iFR is a diagnostic tool used to assess whether a stenosis is causing a limitation of blood flow in coronary arteries with subsequent ischemia. This tool preserves the advantages of physiology-based...

Approved by the FDA in March...

12/05/2014

Cath Lab Digest